Showing 1,981 - 2,000 results of 7,343 for search 'significantly ((((larger decrease) OR (we decrease))) OR (((teer decrease) OR (greater decrease))))', query time: 0.49s Refine Results
  1. 1981

    Adverse event list. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  2. 1982

    Patient characteristics. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  3. 1983

    The basic flowchart of analysis in this study. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  4. 1984

    The enriched GO terms of the 19 DECAGs. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  5. 1985

    Primers of the tested genes. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  6. 1986

    Summary of patient demographic characteristics. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  7. 1987

    S1 Dataset - by Edgar Innocent Guma (20370676)

    Published 2024
    “…<div><p>Interpersonal violence is a significant public health and human rights concern. …”
  8. 1988

    Detailed sequences of primers for PCR. by Jiangli Zhao (2308330)

    Published 2025
    “…N7-methylguanosine (m7G) is a prevalent RNA modification that has attracted significant attention in recent research. In this study, we investigated the regulatory pattern and clinical significance of m7G methylation in epilepsy. …”
  9. 1989

    Qualitative changes in the implant subgroup. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  10. 1990

    Results of the colorimetric MTT test. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  11. 1991

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  12. 1992

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  13. 1993
  14. 1994

    Key safety measures including adverse events. by Anuja Dokras (8679261)

    Published 2025
    “…As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.…”
  15. 1995
  16. 1996

    Imformation. by Shicheng Luo (14349225)

    Published 2025
    “…Flow cytometry revealed a significant decrease in the apoptosis of HK-2 cells. …”
  17. 1997

    Scale scores of all participants. by Sylwia Sumińska (21169999)

    Published 2025
    “…However, a notable difference emerged between the two MBSR groups: in the group with smartwatches, a significant increase in mindfulness was observed. In contrast, in the MBSR group without smartwatches, there was a significant decrease across multiple stress-related components, including: anxiety, cognitive impairment, addictions, sleep disorders symptoms, behaviors indicating lack of entertainment, and poor functioning.…”
  18. 1998

    Variability in performance and response to task dynamics. by Daniel Ramandi (10047543)

    Published 2025
    “…(B) The analysis of trajectory variability, quantified as DTW distance of consecutive trials, showed a non-significant trend towards greater variability in zQ175 mice, peaking later compared to WT mice (RM two-way ANOVA, genotype p = 0.070 F(1, 20) = 3.660, trial p = 0.0005 F(4.291, 85.82) = 5.351, interaction p = 0.542 F(19, 380) = 0.9329). …”
  19. 1999

    European study sites. by Graeme T. Swindles (7192745)

    Published 2025
    “…The highest aPAR values are found in the Scandinavian and Baltic regions, in contrast to Britain, Ireland, and Continental Europe. We find that summer temperature is a significant climatic control on aPAR across our European sites. …”
  20. 2000

    Location of study sites. by Graeme T. Swindles (7192745)

    Published 2025
    “…The highest aPAR values are found in the Scandinavian and Baltic regions, in contrast to Britain, Ireland, and Continental Europe. We find that summer temperature is a significant climatic control on aPAR across our European sites. …”